Evidence map›Paper›PMID 41588234›Full record

ArticleCommunications chemistry2026

Lactam enables remote boronate rearrangements to C═N bonds.

Jie Lei, Jia Xu, Xue Li, Wei Yan, Zhongzhu Chen, Zhigang Xu, Hong-Yu Li

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jie Lei *College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing, China.ORCID http://orcid.org/0000-0001-5719-0798
Jia Xu *College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing, China.
Xue LiCollege of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing, China.
Wei YanDepartment of Pharmacology, College of Medicine, University of Texas Health San Antonio, San Antonio, TX, US.ORCID http://orcid.org/0000-0003-1535-3100
Zhongzhu ChenCollege of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing, China. 18883138277@163.com.ORCID http://orcid.org/0000-0001-9555-6738
Zhigang XuCollege of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing, China. xzg@cqwu.edu.cn.ORCID http://orcid.org/0000-0003-0190-1313
Hong-Yu LiDepartment of Pharmacology, College of Medicine, University of Texas Health San Antonio, San Antonio, TX, US. lih1@uthscsa.edu.ORCID http://orcid.org/0000-0001-9212-2010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remote boronate rearrangement of boronic acids to C═N bonds is a valuable in synthetic chemistry. Conventional approaches are constrained by the need to pre-install specialized directing groups onto the starting materials. Here, we report a lactam-driven dynamic directing strategy, achieving 1,5- and 1,4-boronate rearrangements. The strategy circumvents the need for substrate pre-activation procedures, successfully overcoming a challenge in the functionalization of inactive C = N bonds to N-alkyl anilines and 3-aryl quinoxalinones. Comprehensive mechanistic investigations unveil three transformative insights: (i) Lactam leverages boron activation to C = N bonds through tetracoordinate boron species; (ii) the 1,5-boronate rearrangement to N-alkyl anilines is favored via an eight-membered boronate complex, as supported by density functional theory (DFT) studies; (iii) a catalyst-free 1,4-boronate rearrangement pathway operates through HFIP-stabilized tetracoordinate boron intermediates. This lactam-enabled boronate rearrangements offers a methodology with transformative potential.

Identifiers

PMID41588234
PMCPMC12910007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.